Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: firstname.lastname@example.org
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Doctors 'prescribe' fresh produce with help from food banks
25 Sep 2016 at 8:27am
OAK FOREST, Ill. (AP) ? Six health clinics are working with the Chicago food bank to host a mobile pantry filled with fresh produce ? a trend increasingly seen nationwide as food banks try to improve the diets of poor people with chronic health issues.
Mother uncovers lasting impact of baby son's organ donation
25 Sep 2016 at 7:14am
An ultrasound showed one of Sarah Gray's unborn twins was missing part of his brain, a fatal birth defect. His brother was born healthy but Thomas lived just six days. Latching onto hope for something ...
AIDS pageant in Uganda seeks to stem stigma, discrimination
25 Sep 2016 at 6:53am
KAMPALA, Uganda (AP) ? When she was younger, Tryphena Natukunda's mother discouraged her from swallowing her antiretroviral medicines among strangers or even distant relatives.
UK doctors call off strike action
24 Sep 2016 at 2:13pm
The British Medical Association (BMA) had planned a full withdrawal of labor by junior doctors on Oct. 5-7 and 10-11, Nov. 14-18 and Dec. 5-9, which would have been the longest stoppages in the nearly 70-year history of the National Health Service. Junior doctors - a term covering recent medical school graduates right through to doctors who have been working for well over a decade - have staged a series of walkouts over a new work contract the government plans to impose next month. The BMA said its decision to suspend the action follows feedback from doctors, patients and the public, and discussions with NHS England about the ability of the NHS to maintain a safe service if industrial action were to go ahead.
Thousands march in Dublin, abroad for Irish abortion rights
24 Sep 2016 at 9:18am
By Padraic Halpin DUBLIN (Reuters) - Thousands of protestors marched in Dublin, and Irish expatriates joined in demonstrations around the world on Saturday, to put pressure on the Irish government to hold a referendum to repeal restrictive abortion laws. Regulations in the once stridently Catholic Ireland are among the strictest in the world and next month Prime Minister Enda Kenny will call a citizens' assembly to advise the government on whether a vote should be held to boost access to abortion. Demonstrators marched in the rain on government buildings from Dublin's main thoroughfare of O'Connell Street, bringing traffic to a standstill by the River Liffey as they chanted, beat drums and held placards saying "My Body, My Choice".
Feds push back on states targeting Planned Parenthood funds
24 Sep 2016 at 7:37am
WICHITA, Kan. (AP) ? The Obama administration has proposed barring states and other recipients of federal family planning grants from placing their own eligibility restrictions on where the money can go, which would undermine the efforts of 13 Republican-led states to prevent such money from going to Planned Parenthood.
The 10 Healthiest Places to Live in America
24 Sep 2016 at 2:38am
From Hawaii to New Hampshire, here's where to move for your health.
Medically unfit' Fury out of Klitschko rematch
24 Sep 2016 at 2:34am
Next month's world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko was called off on Friday for a second time with the Briton ruled "medically unfit". The fight was due to be held on Oct. 29 in Manchester, having been originally postponed in July when Fury suffered an ankle injury. "Tyson has this week been declared medically unfit to fight," his promoters Hennessy Sports said in a statement without elaborating.
"We don't need to grow more food to cut hunger in Africa" - activist
24 Sep 2016 at 1:23am
By Alex Whiting TURIN, Italy (Thomson Reuters Foundation) - As a young university student of agriculture, Edie Mukiibi believed the latest hybrid seeds which promised bumper crops were the answer to improving the lot of maize farmers in his part of Uganda. He persuaded many to buy the seeds, while working part-time promoting them in Kiboga district in central Uganda. But the consequences were "terrible", he said. When I went back to talk with the farmers I could feel their pain," Mukiibi said. Even worse, the new crops could not be grown with any other crops, so the farmers were left with nothing to fall back on except the bills they had run up for the pesticides, herbicides and fertilisers the maize required, he said. "This is when I started working with farmers ... to diversify (their) farming," said Mukiibi, now vice president of Slow Food International, a grassroots movement of farmers, chefs, activists and academics campaigning to improve the quality of food and the lives of producers.
U.S. presidential contest takes center stage for investors
23 Sep 2016 at 8:00pm
Who becomes the next U.S. president will be a primary focus for Wall Street next week and beyond, starting on Monday with the first debate between candidates Hillary Clinton and Donald Trump. While the White House race has so far had little discernible effect on the market, that may soon change as polls show a tightening race. Clinton's once-comfortable lead in opinion polls has evaporated, and with just over six weeks until Election Day, some investors see a toss-up contest creating volatility in certain sectors, including health insurers, drugmakers and industrials.
Cowboys, heat and rain: 'Magnificent Seven' talk challenging shoot
23 Sep 2016 at 3:02pm
By Piya Sinha-Roy LOS ANGELES (Reuters) - Bringing the American Wild West to life was no easy task, just ask the cast of "The Magnificent Seven," who endured scorching heat and torrential rain in wool costumes in the Louisiana summer. "We had a lot of lightning, thunder issues where we had to shut (production) down, but the heat was just constant," Denzel Washington, who plays bounty hunter Sam Chisholm, told Reuters. "The Magnificent Seven," a remake of the 1960 classic, is directed by Antoine Fuqua and opens in theaters on Friday.
Fury pulls out of Klitschko rematch through injury
23 Sep 2016 at 3:01pm
BERLIN (Reuters) - The world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko on Oct. 29 has been called off for a second time with the Briton ruled "medically unfit". "Tyson has this week been declared medically unfit to fight," Fury's promoters Hennessy Sports said in a brief statement on Friday. "Medical specialists have advised that the condition is too severe to allow him to participate in the rematch and that he will require treatment before going back into the ring." (Reporting by Karolos Grohmann; Editing by Tony Jimenez)
Boxing-'Medically unfit' Fury out of Klitschko rematch
23 Sep 2016 at 3:01pm
* Heavyweight fight called off for second time * Champion Fury's condition is "too severe" (Adds quotes, details) BERLIN, Sept 23 (Reuters) - Next month's world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko was called off on Friday for a second time with the Briton ruled "medically unfit". The fight was due to be held on Oct. 29 in Manchester, having been originally postponed in July when Fury suffered an ankle injury. "Tyson has this week been declared medically unfit to fight," his promoters Hennessy Sports said in a statement without elaborating.
FDA approves Amgen's copy of AbbVie arthritis drug Humira
23 Sep 2016 at 2:51pm
The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar version of AbbVie's top-selling arthritis drug, Humira. The drug, Amjevita, known also as adalimumab-atto, was approved to treat rheumatoid arthritis, psoriatic arthritis, Crohn's disease, psoriasis and other conditions. Amjevita is the fourth biosimilar to be approved by the FDA and is expected to be sold at a discount to the original drug.
Boxing-Fury pulls out of Klitschko rematch through injury
23 Sep 2016 at 2:39pm
BERLIN, Sept 23 (Reuters) - The world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko on Oct. 29 has been called off for a second time with the Briton ruled "medically unfit". "Tyson has this week been declared medically unfit to fight," Fury's promoters Hennessy Sports said in a brief statement on Friday. "Medical specialists have advised that the condition is too severe to allow him to participate in the rematch and that he will require treatment before going back into the ring." (Reporting by Karolos Grohmann; Editing by Tony Jimenez)